Persistent thrombocytosis in patients with cancer needs workup because it can be linked to essential thrombocytosis. The management should be individualized to start treatment for low-risk essential thrombocytosis due to the combined risk of thrombosis.
CITATION STYLE
Ali, E. A., Elmalik, H., Omar, N. E., & Yassin, M. A. (2021). Invasive ductal breast carcinoma preceded by CALR-positive essential thrombocythemia. Clinical Case Reports, 9(3), 1732–1736. https://doi.org/10.1002/ccr3.3892
Mendeley helps you to discover research relevant for your work.